Enhancing Pharmacovigilance Intake Processes With AI And Automation

Discover how AI and automation can transform pharmacovigilance in this insightful webinar.

Julie Girod, associate vice president and global head of Case Management and Medical Evaluation at Sanofi and Daunielle Chipman, senior director at IQVIA will show how Sanofi’s patient safety group, PSPV, has optimized intake processes to support its mission of maximizing benefit-risk for patients worldwide. Managing around 700,000 adverse reactions annually, PSPV is at the forefront of integrating technology to enhance safety operations.

Traditional pharmacovigilance intake is manual, time-consuming and prone to error. These challenges can delay safety reporting, inflate costs, and compromise data integrity.

This webinar session will explore the evolution of the ARTEMIS (Adverse Event Processing using Technology Enabled Medical and Intelligent Solution) project launched by PSPV and Sanofi Digital 6 years ago with a previous partner which was achieving significant benefits through NLP and Artificial Intelligence. Then due to unforeseen constraints Sanofi started working with IQVIA to move to a new system within 6 months and continue the journey of optimization and improvement.

This partnership showcases how organizations can stay adaptable, even through shifting circumstances, to sustain momentum in digital safety innovation.

Key Takeaways:

• Efficiency Gains: Learn how AI can streamline intake processes, reducing the time and effort required for data handling.
• Collaborative Innovation: Gain insights into how Sanofi and IQVIA maintained progress and adapted in response to evolving needs in patient safety.
• Actionable Insights: Gain practical ideas on adapting and adopting similar strategies to improve your pharmacovigilance operations.

Watch on-demand →